Wednesday, December 8, 2021

SPARC inks licensing pact with Visiox Pharma for ophthalmic products

SPARC inks licensing pact with Visiox Pharma for ophthalmic products The company has entered into an agreement with Visiox Pharma LLC (Visiox) to grant exclusive worldwide rights (except for India and Greater China) for the development and commercialisation of PDP-716 and SDN-037, SPARC said in a statement.

from Moneycontrol Business News https://ift.tt/3IumBz4
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...